Bank Multiarta Sentosa Tbk. vs Merck Tbk. — how do they compare? Bank Multiarta Sentosa Tbk. trades at Rp3,390 (market cap 4.7T, 10.8K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Bank Multiarta Sentosa Tbk. is far larger — about 2.8× Merck Tbk.'s market cap, and Merck Tbk. is more actively traded (37.6K versus 10.8K). Which is the better fit depends on your goals.
| MASB | MERK | |
|---|---|---|
Market Cap | 4.7T | 1.7T |
Volume | 10.8K | 37.6K |
Lot | 108 | 376 |
Turnover | 36.52M | 144.47M |
Average Price | 3,381.85 | 3,842.23 |
Value | 36.52M | 144.47M |
Indicative Equilibrium Price | — | 3,840 |
Indicative Equilibrium Volume | — | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Multiarta Sentosa Tbk (the Bank) was established by Deed No.201 dated July 28, 1992 of H.Saidus Sjahar, S.H. The Bank's parent company is PT Danabina Sentana which is the majority stockholder of the Bank. The majority shareholder of PT Danabina Sentana is PT Lumbung Artakencana which is a company established in Indonesia and the Bank’s ultimate shareholder that joined in business group of Wings Group.
Read more on MASB →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →